Die neue internationale Sepsis-Leitlinie der Surviving Sepsis Campaign 2021

Die Surviving Sepsis Campaign (SSC) veröffentlichte im Oktober 2021 eine Aktualisierung der zuletzt im Jahr 2016 überarbeiteten SSC-Leitlinie zur Diagnostik und Behandlung der Sepsis und des septischen Schocks bei Erwachsenen. Der Artikel fasst die aktuellen Empfehlungen zur Akuttherapie praxisrelevant zusammen und stellt die Unterschiede zur vorherigen Version und der aktuellen S3-Leitlinie der Deutschen Sepsis-Gesellschaft heraus.

Abstract

The new Surviving Sepsis Campaign (SSC) guideline was substantially revised in 2021. These updated recommendations are intended to guide intensivists in providing adequate care to adult patients with sepsis or septic shock. In particular, the current SSC guideline emphasizes early recognition and stringent management in the first hours after the onset of sepsis. In particular, the implementation of acute interventions should help to improve the chances of survival of sepsis patients.

This article summarizes the most important recommendations for acute therapy and presents them as a comparative overview to the previous SSC guideline and the German S3 guideline. This should allow the reader to adopt the knowledge from the new guideline into clinical practice as quickly as possible in order to improve the quality of treatment of patients with sepsis or septic shock.

Kernaussagen

• Zur Frühkennung einer Sepsis sollte der qSOFA-Score nicht als alleiniges Screening-Instrument verwendet werden. Die SIRS-Kriterien sowie der NEWS- und MEWS-Score stellen sinnvolle Erweiterungen dar.

• Bei Gabe des initialen Flüssigkeitsbolus sollte ein Assessment auf das Vorliegen einer Hypoperfusion, unter anderem mithilfe der Rekapillarisierungszeit, durchgeführt werden.

• Zur hämodynamischen Stabilisierung sollten balancierte Vollelektrolytlösungen verabreicht werden.

• Bei geringer Wahrscheinlichkeit für eine Sepsis und ohne Zeichen des septischen Schocks ist es vertretbar, weitere Diagnostik durchzuführen und Antibiotika innerhalb eines 3-h-Zeitrahmens zu verabreichen.

• Von extrakorporalen Blutreinigungstechniken sowie der Gabe von Vitamin C oder Levosimendan sollte in der Sepsis abgesehen werden.

Schlüsselwörter

Sepsis - septischer Schock - Leitlinie - Surviving-Sepsis-Campaign - SSC

Keywords

sepsis - septic shock - guideline - Surviving-Sepsis-Campaign - SSC

Publication History

Article published online:
19 May 2022

• Literatur

• 1 Singer M, Deutschman CS, Seymour CW. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315: 801 DOI: 10.1001/jama.2016.0287. (PMID: 26903338)
• 2 Rudd KE, Johnson SC, Agesa KM. et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet 2020; 395: 200-211 DOI: 10.1016/S0140-6736(19)32989-7. (PMID: 31954465)
• 3 Marx G. SepNet Critical Care Trials group. Correction to: incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study. Intensive Care Med 2018; 44: 153-156 DOI: 10.1007/s00134-017-4980-0.
• 4 Evans L, Rhodes A, Alhazzani W. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 2021; 47: 1181-1247 DOI: 10.1007/s00134-021-06506-y. (PMID: 34599691)
• 5 Damiani E, Donati A, Serafini G. et al. Effect of performance improvement programs on compliance with sepsis bundles and mortality: a systematic review and meta-analysis of observational studies. PLoS One 2015; 10: e0125827 DOI: 10.1371/journal.pone.0125827. (PMID: 25946168)
• 6 Schorr C, Odden A, Evans L. et al. Implementation of a multicenter performance improvement program for early detection and treatment of severe sepsis in general medical-surgical wards: Program for Early Detection of Sepsis. J Hosp Med 2016; 11: S32-S39 DOI: 10.1002/jhm.2656. (PMID: 27805796)
• 7 Islam MM, Nasrin T, Walther BA. et al. Prediction of sepsis patients using machine learning approach: A meta-analysis. Comput Methods Programs Biomed 2019; 170: 1-9 DOI: 10.1016/j.cmpb.2018.12.027. (PMID: 30712598)
• 8 Branch-Elliman W, O’Brien W, Strymish J. et al. Association of duration and type of surgical prophylaxis with antimicrobial-associated adverse events. JAMA Surg 2019; 154: 590 DOI: 10.1001/jamasurg.2019.0569. (PMID: 31017647)
• 9 Hranjec T, Rosenberger LH, Swenson B. et al. Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. Lancet Infect Dis 2012; 12: 774-780 DOI: 10.1016/S1473-3099(12)70151-2. (PMID: 22951600)
• 10 Tamma PD, Avdic E, Li DX. et al. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med 2017; 177: 1308 DOI: 10.1001/jamainternmed.2017.1938. (PMID: 28604925)
• 11 Teshome BF, Vouri SM, Hampton N. et al. Duration of exposure to antipseudomonal β-lactam antibiotics in the critically ill and development of new resistance. Pharmacotherapy 2019; 39: 261-270 DOI: 10.1002/phar.2201. (PMID: 30506852)
• 12 Seymour CW, Gesten F, Prescott HC. et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med 2017; 376: 2235-2244 DOI: 10.1056/NEJMoa1703058. (PMID: 28528569)
• 13 Awad S, Allison SP, Lobo DN. The history of 0.9% saline. Clin Nutrit 2008; 27: 179-188 DOI: 10.1016/j.clnu.2008.01.008. (PMID: 18313809)
• 14 Zampieri FG, Machado FR, Biondi RS. et al. Effect of intravenous fluid treatment with a balanced solution vs 0.9% saline solution on mortality in critically ill patients: The BaSICS randomized clinical trial. JAMA 2021; 326: 1-12 DOI: 10.1001/jama.2021.11684.
• 15 Gordon AC, Perkins GD, Singer M. et al. Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 2016; 375: 1638-1648 DOI: 10.1056/NEJMoa1609409. (PMID: 27705084)
• 16 Bhattacharjee S, Soni KD, Maitra S. et al. Levosimendan does not provide mortality benefit over dobutamine in adult patients with septic shock: A meta-analysis of randomized controlled trials. J Clin Anesth 2017; 39: 67-72 DOI: 10.1016/j.jclinane.2017.03.011. (PMID: 28494911)
• 17 Mauri T, Turrini C, Eronia N. et al. Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med 2017; 195: 1207-1215 DOI: 10.1164/rccm.201605-0916OC. (PMID: 27997805)
• 18 Rygård SL, Butler E, Granholm A. et al. Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 2018; 44: 1003-1016 DOI: 10.1007/s00134-018-5197-6. (PMID: 29761216)
• 19 Marik PE, Khangoora V, Rivera R. et al. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest 2017; 151: 1229-1238 DOI: 10.1016/j.chest.2016.11.036. (PMID: 27940189)
• 20 Putzu A, Daems AM, Lopez-Delgado JC. et al. The effect of vitamin C on clinical outcome in critically ill patients: a systematic review with meta-analysis of randomized controlled trials. Critical Care Medicine 2019; 47: 774-783 DOI: 10.1097/CCM.0000000000003700. (PMID: 30839358)